Related Experiment Videos
Chromosomal aberrations in vitro induced by aneugens
Mutation Research
|October 23, 1997
Summary
This study investigated aneugens like colcemid, colchicine, and vincristine. Results show these compounds do not directly link cell division disruption to structural chromosomal aberrations.
Area of Science:
- Cytogenetics
- Molecular Toxicology
- Cell Biology
Background:
- Aneugens are known to disrupt cell division and possess aneugenic potential.
- A potential link between aneugen-induced cell division disturbance and clastogenic effects requires investigation.
Purpose of the Study:
- To determine if a relationship exists between cell division disturbance and clastogenic potential of aneugens.
- To investigate the induction of structural chromosomal aberrations, polyploid cells, and mitotic index alterations by colcemid, colchicine, and vincristine in CHO cells.
Main Methods:
- Chinese Hamster Ovary (CHO) cells were treated with varying concentrations of colcemid, colchicine, and vincristine.
- Analysis included assessment of structural chromosomal aberrations, polyploidy, and mitotic index.
- Dose-response effects and clastogenic potential in both diploid and tetraploid cells were evaluated.
Main Results:
- Low to intermediate concentrations of aneugens increased polyploidy and mitotic index but did not induce structural aberrations.
- High concentrations of colcemid and colchicine induced structural aberrations in diploid cells; colchicine and vincristine were clastogenic in tetraploid cells.
- A threshold effect was observed for clastogenicity, and tetraploidy itself was associated with increased aberrations, independent of aneugen treatment.
Conclusions:
- No direct relationship was found between aneugen-induced cell cycle disturbance and the incidence of structural chromosomal aberrations for the tested compounds.
- The clastogenic effects of aneugens are concentration-dependent and can occur in polyploid cells.
- Tetraploid cells exhibit a higher baseline frequency of structural chromosomal aberrations.